MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-40 |
Device Problems
Material Integrity Problem (2978); Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
|
Patient Problems
Unspecified Infection (1930); Scar Tissue (2060); Device Embedded In Tissue or Plaque (3165)
|
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: product id: 8709, serial#: (b)(4), implanted: (b)(6) 2010, explanted: (b)(6) 2020, product type: catheter.Product id: 8709, serial#: (b)(4), implanted: (b)(6) 2010, explanted: (b)(6) 2020, product type: catheter.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a healthcare provider (hcp) via a manufacturer representative on (b)(6) 2020 regarding a patient receiving gablofen (dose and concentration unknown) via an implanted infusion pump.It was reported that the hcp was trying to explant the entire system due to infection.The pump and majority of the catheter had been explanted, but the hcp was struggling to get the remaining portion of the spinal segment explanted.It was unknown if the issue was resolved at the time of report.
|
|
Manufacturer Narrative
|
Continuation of d10: product id 8709 lot# serial# (b)(6).Implanted: (b)(6) 2010.Explanted: (b)(6) 2020.Product type catheter medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from the healthcare provider (hcp) on (b)(6) 2021.It was reported that the orphan/fractured segment of the catheter, which was located midthoracic between t8 and t11 could not be explanted because it was densely encapsulated in scar tissue and was fractured in multiple places.It was confirmed that the patient's infection had resolved.
|
|
Manufacturer Narrative
|
H3: non-destructive analysis was performed and no anomalies were found.Continuation of d10: product id: 8709, serial# (b)(6), implanted: (b)(6) 2010, explanted: (b)(6) 2020, product type: catheter; product id: 8709, serial# (b)(6), implanted: (b)(6) 2010, explanted: (b)(6) 2020, product type: catheter.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|